摘要
对100例维持性血液透析及肾移植患者,进行了血清丙型肝炎抗体(抗 HCV)的检测,发现抗 HCV阳性率为41.0%,其中肾移植术后再透析者达56.52%。且透析时间越长、输血次数越多,受血量越大者,抗 HCV 阳性率越高(r=0.901,P<0.05;r=0.949.P<0.01)。提出尽快开展对献血员抗 HCV的检测,加强消毒隔离是降低丙型肝炎发生率的主要措施。
The antibody to HCV in the sera samples of 100 patients rcceived hemodial ysis or kidney transplantation was dctected. It was found that; 1)The rate of anti-HCV detec tion was 41% in these patients and 56. 52% in the patients received continual hemodialysisafter kidney transplantation;2)The duration of hemodialysis and the times (or the volumes) of recciving transfusion were positively correlated with the rate of anti-HCV detection (Υ = 0. 901,P<0. 05;Υ=0. 904,P<0. 01 .respectively). It was concluded that selection of anti-HCV negative blood donors and disinfection of hemodialysis units thoroughly are the main measures to prevent HCV infection in this special population.
出处
《华中科技大学学报(医学版)》
CAS
CSCD
北大核心
1993年第S1期37-39,共3页
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词
抗体
丙型肝炎
血液透析
肾移植
HCV antibody
hemodialysis
kidney transplantation